Jun 17, 2025 06:34AM H.C. Wainwright Assumes Galectin Therapeutics (GALT) at Buy

May 19, 2025 05:02AM Increasing unusual option volume: INFA TDUP ADT SPCE CG AMCR DBRG GALT

May 16, 2025 10:14AM Increasing unusual call option volume: TDUP GALT ACAD MBOT SEAT CIVI TSSI DOCS UNH DBRG

May 15, 2025 04:58PM Galectin Therapeutics (GALT) Tops Q1 EPS by 5c

May 12, 2025 08:07AM Galectin Therapeutics (GALT) Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress

Feb 18, 2025 08:06AM Galectin Therapeutics (GALT) Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial

Dec 27, 2024 12:32PM H.C. Wainwright Downgrades Galectin Therapeutics (GALT) to Neutral

Dec 23, 2024 05:35AM Increasing unusual put option volume: RGTI GALT CNC QBTS EXE ANAB BAX KDP ETHU

Dec 23, 2024 05:33AM Increasing unusual option volume: GALT QUBT AMCR ARQT CE KULR CNC AMTM RGTI CRVS HMC

Dec 20, 2024 08:01AM Galectin Therapeutics (GALT) Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH

Dec 17, 2024 10:06AM Increasing unusual put option volume: AEO QBTS GALT RCAT TEVA EQNR DINO IBRX BBAI

Dec 16, 2024 09:52AM Increasing unusual option volume: GALT CKPT BZUN QUBT ITUB RCAT BIRK BBD RGTI

Dec 16, 2024 05:14AM Increasing unusual put option volume: GALT NWL ACHR IAU QBTS CIEN VTRS BAH

Aug 13, 2024 08:53AM Galectin Therapeutics (GALT) Misses Q2 EPS by 4c

Aug 1, 2024 08:02AM Galectin Therapeutics (GALT) Appoints Khurram Jamil, M.D. to Chief Medical Officer